Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis. (Q34415570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

14

Toshifumi Hibi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Nagamu Inoue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Tadakazu Hisamatsu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Susumu Okamoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Katsuyoshi Matsuoka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Toshiro Sato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Hiroshi Chinen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Kyong Su Hong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Takaya Yamada

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Yumiko Suzuki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Tatsuo Suzuki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Noriaki Watanabe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Kanji Tsuchimoto

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

455-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Disease

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Effect of probiotic strains on interleukin 8 production by HT29/19A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Functional modulation of enterocytes by gram-positive and gram-negative microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000158158.55955.DE

10.1097/01.MIB.0000158158.55955.DE

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867585%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference